<i>BRCA</i> Mutations and Breast Cancer Prevention

by Joanne Kotsopoulos
Published 2018-12-01

Differences in Ovarian and Other Cancers Risks by Population and <i>BRCA</i> Mutation Location

by Masayuki Sekine, Koji Nishino, Takayuki Enomoto
Published 2021-07-01

Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study

by Francesco Plotti, Corrado Terranova, Federica Guzzo, Carlo De Cicco Nardone, Daniela Luvero, Martina Bartolone, Camilla Dionisi, Domenico Benvenuto, Silvia Fabris, Massimo Ciccozzi, Violante Di Donato, Pierluigi Benedetti Panici, Roberto Angioli
Published 2021-01-01

Spectrum of Germline <i>BRCA1 </i>and<i> BRCA2</i> Variants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of Rome

by Concetta Santonocito, Roberta Rizza, Ida Paris, Laura De Marchis, Carmela Paolillo, Giordana Tiberi, Giovanni Scambia, Ettore Capoluongo
Published 2020-05-01

Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy

by Caterina Fumagalli, Federica Tomao, Ilaria Betella, Alessandra Rappa, Mariarosaria Calvello, Bernardo Bonanni, Loris Bernard, Fedro Peccatori, Nicoletta Colombo, Giuseppe Viale, Massimo Barberis, Elena Guerini-Rocco
Published 2019-10-01

BRCA Methylation Testing Identifies a Subset of Ovarian Carcinomas without Germline Variants That Can Benefit from PARP Inhibitor

by Nora Sahnane, Ileana Carnevali, Giorgio Formenti, Jvan Casarin, Sofia Facchi, Raffaella Bombelli, Eleonora Di Lauro, Domenico Memoli, Annamaria Salvati, Francesca Rizzo, Fausto Sessa, Maria Grazia Tibiletti
Published 2020-12-01

Comparative Expression of Breast Cancer 1 Tumor Suppressor Protein in Cancerous and Healthy Colorectal Specimens

by Mehdi Nikbakht-Dastjerdi, Vahid Kashanian
Published 2016-03-01

PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers

by Man Yee T. Keung, Yanyuan Wu, Jaydutt V. Vadgama
Published 2019-03-01

<i>BRCA</i> Genes and Related Cancers: A Meta-Analysis from Epidemiological Cohort Studies

by Yen-Chien Lee, Yen-Ling Lee, Chung-Yi Li
Published 2021-08-01

Prognostic Impact of <i>BRCA1</i> and <i>BRCA2</i> Mutations on Long-Term Survival Outcomes in Egyptian Female Breast Cancer Patients

by Sherihan AbdelHamid, Hala El-Mesallamy, Hany Abdel Aziz, Abdel-Rahman Zekri
Published 2021-06-01

Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide

by Yosuke Hirotsu, Udo Schmidt-Edelkraut, Hiroshi Nakagomi, Ikuko Sakamoto, Markus Hartenfeller, Ram Narang, Theodoros G. Soldatos, Sajo Kaduthanam, Xiaoyue Wang, Stephan Hettich, Stephan Brock, David B. Jackson, Masao Omata
Published 2020-05-01

<i>BRCA1</i> and <i>BRCA2</i> Gene Mutations and Lung Cancer Sisk: A Meta-Analysis

by Yen-Chien Lee, Yang-Cheng Lee, Chung-Yi Li, Yen-Ling Lee, Bae-Ling Chen
Published 2020-04-01

Consistency of the Tools That Predict the Impact of Single Nucleotide Variants (SNVs) on Gene Functionality: The <i>BRCA1</i> Gene

by Javier Murillo, Flavio Spetale, Serge Guillaume, Pilar Bulacio, Ignacio Garcia Labari, Olivier Cailloux, Sebastien Destercke, Elizabeth Tapia
Published 2020-03-01

<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories

by Ettore Capoluongo, Nicla La Verde, Massimo Barberis, Maria Angela Bella, Fiamma Buttitta, Paola Carrera, Nicoletta Colombo, Laura Cortesi, Maurizio Genuardi, Massimo Gion, Valentina Guarneri, Domenica Lorusso, Antonio Marchetti, Paolo Marchetti, Nicola Normanno, Barbara Pasini, Matilde Pensabene, Sandro Pignata, Paolo Radice, Enrico Ricevuto, Anna Sapino, Pierosandro Tagliaferri, Pierfrancesco Tassone, Chiara Trevisiol, Mauro Truini, Liliana Varesco, Antonio Russo, Stefania Gori
Published 2019-10-01

Solid Pseudopapillary Neoplasm of the Pancreas and Abdominal Desmoid Tumor in a Patient Carrying Two Different <i>BRCA2</i> Germline Mutations: New Horizons from Tumor Molecular Pr...

by Andrea Mafficini, Rita T. Lawlor, Claudio Ghimenton, Davide Antonello, Cinzia Cantù, Gaetano Paolino, Alessia Nottegar, Maria L. Piredda, Roberto Salvia, Michele Milella, Angelo P. Dei Tos, Matteo Fassan, Aldo Scarpa, Claudio Luchini
Published 2021-03-01

Feasibility of <i>BRCA1/2</i> Testing of Formalin-Fixed and Paraffin-Embedded Pancreatic Tumor Samples: A Consecutive Clinical Series

by Rossella Bruno, Elisa Sensi, Cristiana Lupi, Mirella Giordano, Laura Bernardini, Caterina Vivaldi, Lorenzo Fornaro, Enrico Vasile, Daniela Campani, Gabriella Fontanini
Published 2021-06-01

Tumour Versus Germline <i>BRCA</i> Testing in Ovarian Cancer: A Single-Site Institution Experience in the United Kingdom

by Iolia Akaev, Siavash Rahimi, Olubukola Onifade, Francis John Edward Gardner, David Castells-Rufas, Eleanor Jones, Shyamika Acharige, Chit Cheng Yeoh
Published 2021-03-01

Breast-Specific Epigenetic Regulation of DeltaNp73 and Its Role in DNA-Damage-Response of <i>BRCA1</i>-Mutated Human Mammary Epithelial Cells

by Ayelet Avraham, Susanna Feldman, Sean Soonweng Cho, Ayala Kol, Lior Heler, Emmanuela Riklin-Nahmias, Avishay Sella, Tamar Karni, Tanir M. Allweis, Saraswati Sukumar, Ella Evron
Published 2020-08-01

Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors

by Mattia Garutti, Giacomo Pelizzari, Michele Bartoletti, Matilde Clarissa Malfatti, Lorenzo Gerratana, Gianluca Tell, Fabio Puglisi
Published 2019-07-01

Tailoring Ovarian Cancer Treatment: Implications of <i>BRCA1/2</i> Mutations

by Ainhoa Madariaga, Stephanie Lheureux, Amit M. Oza
Published 2019-03-01